L30- Future Treatment Flashcards
Which drug which was for duchenne muscular dystrophy was studied for class 1 mutations (brodlie et Al 2015)
Ataluren
How many have class 1 mutations
5-10%
What did ataluren propose to do
Help ribosomes skip over the ptc due to the nonsense mutation class 1 in CFTR. This made a functional CFTR protein
What was found in the first clinical trials
Increased expression of CFTR in basal epi cells when administered and no adverse effects
Why was ataluren not marketed
In phase 3 found no fev1 change or sweat Cl in patients
Modulators aren’t cures. What is
Gene therapy
What is the major issue with Gene therapy
The viral and non viral vectors can have issues when administered and sometimes not tolerated by body
What is a non viral vector example
Liposomes which are fat droplets
What is a good thing about then
When inhaled or nebulised spray they can easily be absorbed into the cell membrane and nucleus
In what patients did fev increase in first trials with liposomes
Only with severe diseqse
Why was it discontinued
Not as good as modulators and the fev1 showed fluctuation
Which article discusses different vectors for gene therapy
Burnley 2012
Why was adenovirus not a good idea
Causes inflammation and toxicity signs in the clinical trials
Why was adeno associated viruses AAV used instead but why did it fail
Less pathogenic but we’re too small to package the CFTR gene
Which type of virus was good because can target both non dividing and dividing cells
Lentiviruses